FindTrial
Sign In

Studies on clinical and pathological characteristics in patients with pigment dispersion syndrome

Proteomics of the irides in patients with pigment dispersion syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-12002031
Enrollment
Unknown
Registered
2012-03-20
Start date
2012-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pigment dispersion syndrome

Interventions

None listed

Sponsors

Beijing Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: patients with two or more of the following signs: 1. Krukenberg spindle; 2. Homogeneous trabecular meshwork pigmentation; 3. Zentamayer ring and/or Scheie's line.

Exclusion criteria

Exclusion criteria: patients with a history of cilliary or choloidal tumor, trauma, intraocular laser treatment or inflammation.

Design outcomes

Primary

MeasureTime frame
intraocular presure;anterior chamber dephth;axial length;—

Countries

China

Contacts

Public ContactQing Guoping M.D. Ph.D.
gptsing@126.com+86 15801224486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026